Related Experiment Video
Updated: Jun 16, 2026

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
Published on: July 9, 2014
[Safety and immunogenicity of lyophilized live attenuated domestic varicella vaccine]
En-Fu Chen1, Zheng-Gang Jiang, Qian Li
1Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou 310051, Zhejiang, China.
Objective:
To evaluate the safety and immunogenicity of the lyophilized live attenuated domestic varicella vaccine of Oka strain in Zhejiang province.
Methods:
785 susceptible children aged 1-13 years, who had no history of VZV infection and had not been immunized, were observed. RESULTS The results showed that 2.29% children had adverse reactions after 30 mins of inoculation, 3.69% children had adverse reactions after 4 hours, 3.82% children had adverse reactions after 24 hours, 1.78% children had adverse reactions after 48 hours, 0.25% children had adverse reactions after 72 hours, no adverse reactions were observed after six weeks. There were 3.82% children had fever, The incidence rate of other adverse reactions such as swell and scleroma were low. The vaccine had high sero-converson rate.
Conclusion:
The results showed that it has good safety and immunogenicity of the live attenuated domestic varicella vaccine.
Related Concept Videos
Chickenpox
Vaccines
Smallpox
Vaccinations
Poliomyelitis
Vaccine Production

